Irritable Bowel Syndrome
Kathryn Welp
Background
- Diagnose by the Rome IV criteria, no longer a diagnosis of exclusion
- Recurrent abdominal pain on average at least 1 day/week in the last 3 months with an onset at least 6 months prior, associated with two or more of the following criteria
- Pain related to defecation
- Change in frequency of stool
- Change in form (appearance) of stool
- Patient has none of the following warning signs: >50yrs, evidence of GIB, nocturnal pain or BMs, unintentional weight loss, family hx of colorectal cancer or IBD, palpable abdominal mass or LAD, IDA, +FOBT
- Classified based on predominant bowel habits
- Diarrhea: >25% BMs with Bristol stool types 6 or 7
- Constipation: >25% BMs with Bristol stool types 1 or 2
- Mixed: both of above
Evaluation
- Thorough H&P for alarm symptoms as above
- Consider limited testing with CBC, CMP, CRP, celiac serology (TTG, anti-gliadin, etc), fecal calprotectin
Management
- Lifestyle/Dietary Modifications:
- Increased physical activity, low FODMAP diet (I: Eliminate high FODMAP foods for 4-6 wks, II: Incorporate foods back into diet and see what’s tolerable)
- No evidence for probiotics (can potentially worsen bloating 2/2 SIBO)
- Psychosocial Treatment:
- CBT, psychotherapy, therapeutic physician-patient relationship
- Pharmacologic Treatment:
- Pain: colicky abdominal pain, avoid opioids
- Peppermint oil (smooth muscle relaxant) – IBGuard, Iberogast
- Antispasmodics: Hyosciamine acts faster than Dicyclomine
- TCAs (slow GI transit): Amitriptyline or nortriptyline (causes less constipation so better in IBS-C)
- Diarrhea:
- Ondansetron (8mg TID), Loperamide (up to 16g qd), Rifaximin (550mg BID for 2 wks), Eluxadoline (75-100mg BID); consider Lomotil if refractory
- Constipation:
- Fiber (Ispaghula husk orange), Miralax, Linzess (first line but can be expensive), Trulance, or Amitiza
- Other:
- SSRIs, SNRIs for concomitant mood disorders
- Gabapentin, Lyrica